Dafna Capital Management LLC Vigil Neuroscience, Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.97 - $8.6 $298,464 - $864,239
-100,493 Reduced 58.32%
71,815 $242,000
Q1 2023

May 15, 2023
BUY
$8.77 - $12.7 $30,361 - $43,967
3,462 Added 2.05%
172,308 $1.69 Million
Q4 2022

Feb 14, 2023
SELL
$8.74 - $15.99 $415,578 - $760,308
-47,549 Reduced 21.97%
168,846 $2.11 Million
Q3 2022

Nov 14, 2022
BUY
$2.37 - $9.61 $276,439 - $1.12 Million
116,641 Added 116.93%
216,395 $1.97 Million
Q1 2022

May 16, 2022
BUY
$7.03 - $17.29 $701,270 - $1.72 Million
99,754 New
99,754 $701,000

Others Institutions Holding VIGL

# of Institutions
52
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $54.6M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email